We are live on ! Find out more
MDLN

Medline Inc

405 hedge funds and large institutions have $29.6B invested in Medline Inc in 2026 Q2 according to their latest regulatory filings, with 170 funds opening new positions, 153 increasing their positions, 66 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more repeat investments, than reductions

Existing positions increased: 153 | Existing positions reduced: 66

124% more first-time investments, than exits

New positions opened: 170 | Existing positions closed: 76

29% more funds holding

Funds holding: 314405 (+91)

10.32% more ownership

Funds ownership: 78.44%88.76% (+10%)

5% more capital invested

Capital invested by funds: $28.3B → $29.6B (+$1.32B)

16% less funds holding in top 10

Funds holding in top 10: 1916 (-3)

37% less call options, than puts

Call options by funds: $58.7M | Put options by funds: $93.1M

Holders
405
Holders Change
+91
Holders Change %
+28.98%
% of All Funds
4.89%
Holding in Top 10
16
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-15.79%
% of All Funds
0.19%
New
170
Increased
153
Reduced
66
Closed
76
Calls
$58.7M
Puts
$93.1M
Net Calls
-$34.4M
Net Calls Change
-$110M
Name Holding Trade Value Shares
Change
Change in
Stake
EOJOAM
251
E. Ohman J:or Asset Management
Sweden
$508K +$519K +12,890 New
NDSIB
252
North Dakota State Investment Board
North Dakota
$502K +$513K +12,721 New
Envestnet Portfolio Solutions
253
Envestnet Portfolio Solutions
Illinois
$501K +$86.6K +2,149 +20%
SO
254
STRS Ohio
Ohio
$491K +$189K +4,694 +61%
OAC
255
OMERS Administration Corp
Ontario, Canada
$485K +$113K +2,806 +30%
CFO
256
Callan Family Office
Pennsylvania
$485K +$76.5K +1,899 +18%
MCM
257
Mengis Capital Management
Oregon
$480K +$491K +12,180 New
Fifth Third Bancorp
258
Fifth Third Bancorp
Ohio
$479K +$200K +4,960 +69%
WI
259
Wahed Invest
New York
$463K +$473K +11,733 New
CIS
260
Capital International Sarl
California
$462K -$57.9K -1,437 -11%
VA
261
Vident Advisory
Georgia
$440K +$725 +18 +0.2%
AQR Capital Management
262
AQR Capital Management
Connecticut
$423K +$432K +10,726 New
OMC
263
Overbrook Management Corp
New York
$417K +$426K +10,567 New
KRSITF
264
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$410K +$419K +10,395 New
PNC Financial Services Group
265
PNC Financial Services Group
Pennsylvania
$403K +$327K +8,127 +387%
SC
266
Shay Capital
New York
$394K -$604K -15,000 -60%
Allspring Global Investments
267
Allspring Global Investments
North Carolina
$371K -$54.3M -1,348,667 -99%
SOW
268
State of Wyoming
Wyoming
$368K +$139K +3,441 +58%
OAM
269
Ostrum Asset Management
France
$353K +$361K +8,951 New
P
270
&Partners
Tennessee
$350K +$87.6K +2,175 +33%
Walleye Capital
271
Walleye Capital
New York
$349K -$16M -396,425 -98%
CFFNO
272
Common Fund For Nonprofit Organizations
Connecticut
$337K +$345K +8,551 New
BNP Paribas Asset Management
273
BNP Paribas Asset Management
France
$337K +$344K +8,541 New
TI
274
Tidal Investments
Wisconsin
$334K +$341K +8,471 New
GAM
275
Gotham Asset Management
New York
$323K -$5.94M -147,418 -95%

MDLN Hedge Fund Activity: Q2 2026 in Review

405 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Medline Inc (MDLN) for Q2 2026, worth a combined $29.6B — up 4.7% from $28.3B a quarter earlier.

Buyers outnumbered sellers: 170 funds opened new MDLN positions and 76 closed out — a net gain of 94 holders — while 153 added to existing stakes and 66 trimmed.

The largest buyer was Invesco, adding an estimated $700M. The largest seller was H&F Corporate Investors X, cutting an estimated $629M.

  • 405 institutional investors held Medline Inc (MDLN) as of Q2 2026, up from 314 in Q1 2026.
  • Funds reported $29.6B of Medline Inc stock for Q2 2026, up 4.7% quarter-over-quarter.
  • 170 funds opened new Medline Inc positions in Q2 2026 and 76 closed out, a net change of +94 holders.
  • The largest Medline Inc buyer in Q2 2026 was Invesco, an estimated $700M added.
  • The largest Medline Inc seller in Q2 2026 was H&F Corporate Investors X, an estimated $629M sold.

Based on aggregated 13F filings for Q2 2026.